Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Paris Agreement target off the table, report says - 2Malaysian broadcaster rejects altered graphic about electricity rate hike
- 3Step by step instructions to Pick the Right Dental specialist for Your Dental Inserts Technique
- 4‘More should be done’: UN pushes Syrian regime on justice for Druze, Alawites and minority groups
- 5Instructions to Keep up with Your Traded Teeth for Life span
- Desired Travel Objections Worldwide: Where to Go Straightaway
- How much should a kid's birthday party cost? One mom spent $190 for pizza and ice cream at a park. Another paid $2K for a playspace and goodie bags.
- Seoul says sorry after unapproved drone flights into North Korea
- Ancient eggshells shed new light on crocodiles that hunted prey from trees
- Brexit's Effect on New York's Ascent as a Main Monetary Center
- ISS astronaut evacuation shouldn't interfere with upcoming Artemis 2 moon mission, NASA chief says
- Tributes pour in for MIT professor Nuno Loureiro amid unresolved shooting case
- Finding the Universe of Craftsmanship: Individual Encounters in Imagination
- How did birds survive while dinosaurs went extinct?
